Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
Primary Central Nervous System Tumors - Pathogenesis and Therapy (Paperback, 2011 ed.)
Loot Price: R6,232
Discovery Miles 62 320
|
|
Primary Central Nervous System Tumors - Pathogenesis and Therapy (Paperback, 2011 ed.)
Series: Current Clinical Oncology
Expected to ship within 10 - 15 working days
|
This comprehensive, yet practical, text is a ready collection of
the most up-to-date information on primary CNS tumors. Authored by
a carefully selected group of the world's leading clinicians and
scientists, the book is divided into three sections. The opening
chapters cover general principles, including epidemiology,
pathogenesis, tumor stem cells, supportive care, complications of
therapy, and quality of life. The remaining two sections are
comprised of treatment-oriented chapters covering the spectrum of
gliomas and rarer tumor types. Each of these chapters presents
multi-disciplinary therapeutic approaches and addresses specific
disease concerns. Throughout, the authors incorporate the
cutting-edge advances in molecular biology and genomics that are
revolutionizing neuro-oncology. The result is an important clinical
resource which provides evidence-based data and interpretation
essential to intelligent therapeutic decision making.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
Knowledge Beats Cancer
Albert Stegmann Alberts, Stegman Alberts, Alberts
Paperback
R320
R295
Discovery Miles 2 950
Kennis Klop Kanker
Albert Stegmann Alberts, Stegman Alberts, Alberts
Paperback
R320
R295
Discovery Miles 2 950
Cancer
Susan E Pories, Marsha A Moses, …
Hardcover
R1,611
Discovery Miles 16 110
See more
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.